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Introduction 
Low-energy distal radius fractures normally occur earlier in life than hip and spine fractures 
and may be the first presentation of osteoporosis. Few studies have addressed the association 
between distal radius fracture and osteoporosis. Vitamin D inadequacy is associated with an 
increased risk of hip fractures, but the association with distal radius fractures has not been 
explored.  
Aims  
The aims of this study were to determine the prevalence of patients with a distal radius 
fracture in need of osteoporosis treatment according to certain guidelines, calculate the 
subsequent fracture risk, and to investigate the association between distal radius fracture and 
osteoporosis and vitamin D inadequacy.  
Materials and methods  
Paper I is a cross-sectional study of 1,576 female and 218 male distal radius fracture patients 
aged 50 years and older from Bergen, Kristiansand and Skien. Papers II and III are case-
control studies based on the 664 female and 85 male patients from Bergen and 554 female 
and 54 male controls from the same area.  
Bone mineral density (BMD) was measured by dual energy X-ray absorptiometry (DXA). A 
self-administered questionnaire included information on health and lifestyle factors. A 
fracture risk assessment tool (FRAX®) was used to calculate the 10-year fracture risk. Serum 
25-hydroxyvitamin D (s-25(OH)D) was analysed.  
Results  
The prevalence of T-score  −2.0 and  −2.5 standard deviation (SD) at femoral neck was 
51% and 31% in female and 38% and 20% in male distal radius fracture patients, 
respectively (Paper I). The 10-year FRAX® estimated hip fracture risk in all female and male 
patients was 9% and 6%, respectively. The corresponding figures for female and male 
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patients with osteoporosis were 18% and 16%, respectively. A large proportion of distal 
radius fracture patients with a high 10-year fracture risk did not have osteoporosis. 
In the matched case-control study (Paper II) the prevalence of osteoporosis was 34% in 
female patients compared to 10% in female controls. Among men the figures were 17% and 
13%, respectively. After adjustment for confounding factors by conditional logistic 
regression, osteoporosis was significantly associated with distal radius fractures in both 
women and men. 
The mean s-25(OH)D was 67 nmol/L in female patients and 79 nmol/L in female controls 
(p<0.001) (Paper III). In men the corresponding figures were 65 and 77 nmol/L (p=0.017), 
respectively. In adjusted conditional logistic regression analyses, s-25(OH)D < 50 nmol/L, 
and 50-75 nmol/L were associated with distal radius fractures in women, and s-25(OH)D < 
50 nmol/L was associated with distal radius fractures in men.
Conclusions  
A high proportion of the distal radius fracture patients had osteoporosis compared to 
matched controls. However, a large proportion of the patients were not diagnosed with 
osteoporosis, and many of them had a high FRAX® score without having osteoporosis. 
Furthermore, osteoporosis and vitamin D inadequacy were associated with distal radius 
fractures. Thus, our results indicate that patients aged 50 years and older with a low-energy 
distal radius fracture should be referred to bone densitometry for measurement of BMD, and 
be evaluated for potential risk factors, as well as for vitamin D inadequacy.   
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Definitions
Bias  A methodological error in the collection or interpretation of the 
data 
Bone mass The amount of bone tissue/minerals (mostly calcium and 
phosphorous) contained in a specific volume of bone
Bone mineral density A measure of the density of bone 
Bone densitometry  The quantitative assessment of bone mass 
Confounding  The estimated effect of the exposure being mixed with the 
effect of a different factor 
Epidemiology The study of the distribution and determinants of health-related 
states or events in specified populations and the application of 
this study to control of health problems  
External validity  The extent to which results from a study can be generalised to 
other populations outside the study population (also called 
generalisability) 
Information bias  Bias caused by wrong information about exposure and/or 
outcome caused by faulty methods for obtaining such 
information 
Internal validity The degree to which the estimated outcome or association 
between exposure and outcome is true or valid for the 
population of the study 
Low-energy fracture A fracture resulting from minimal trauma (e.g. falling from 
standing height or lower) 
Osteoporosis A disease characterised by low bone mass and micro-
architectural deterioration of bone tissue leading to enhanced 
skeletal fragility and increased risk of fractures1
Peak bone mass The maximum amount of bone acquired at skeletal maturity. 
Selection bias  Error due to systematic differences in characteristics between 
attendees and non-attendees in a study 
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T-score The number of standard deviations above the mean of healthy 
young individuals at peak bone mass using a reference 
population 
Z-score The number of standard deviations above the mean of age- and 
sex-matched controls 
1.25-dihydroxyvitamin D An active vitamin D hormone, responsible for vitamin D action 
25-hydroxyvitamin D A circulating storage form of vitamin D; a measure of vitamin 
D status 
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1. Introduction 
The distal radius fracture is the most common fracture type in both women and men2, 3. 
Every year approximately 15,000 adults suffer from a distal radius fracture in Norway4. A 
distal radius fracture occurs on average about 15 years earlier in life than a hip fracture5. 
Thus, a distal radius fracture may be the first presentation of osteoporosis. Osteoporosis is 
characterised by low bone mass and micro-architectural deterioration of bone tissue leading 
to enhanced skeletal fragility and increased risk of fractures1. Hence, a good fracture 
prevention strategy might be to designate distal radius fracture patients as an intervention 
group, in order to detect and treat osteoporosis at an early stage. This might reduce the future 
risk of the adverse consequences of osteoporosis5. The increasing elderly population in 
Western society makes it likely that the number of osteoporotic fractures will increase among 
both men and women in the coming years6. Therefore, strategies to reduce the burden of 
osteoporotic fractures are essential7. Today, distal radius fracture patients are often not 
evaluated for possible osteoporosis8-10. This can be explained by the fact that some clinicians 
treating these patients do not link a fracture of the distal radius to osteoporosis, but rather to 
the fall mechanism. On the other hand, some clinicians believe all low-energy distal radius 
fractures in middle-aged and elderly patients are caused by osteoporosis and suggest drug 
treatment without the need of BMD measurements (Appendix 1). The guidelines from the 
Norwegian Medicines Agency (NMA) suggest treatment after a low-energy fracture and a T-
score  −2.0 standard deviation (SD)11. However, the prevalence of distal radius fracture
patients in Norway with indication for osteoporosis treatment is not known. Increased 
knowledge about whether a distal radius fracture is a result of osteoporosis or an unfortunate 
fall is important for further clinical practice. 
1.1 Low-energy distal radius fracture  
A low-energy fracture is defined as a fracture that occurs with the trauma equivalent to that 
generated by a fall from standing height or lower12. It may also synonymously be called 
osteoporotic fracture or fragility fracture. In patients with osteoporosis, practically all types 
of fractures are more frequent. However, there are three kinds which are usually referred to 
as typical osteoporotic fractures, i.e. distal radius fractures, hip fractures and vertebral 
fractures6.  
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1.1.1 Definition of distal radius fracture 
Distal radius fracture was first mentioned by Petit in 170513 and further described by Pouteau 
in 178314, 15. The first published paper on distal radius fractures was by Colles in 181416. 
Colles described the type of distal radius fracture characterised by dorsal angulations of the 
distal fragment occurring within 2-3 cm of the distal end of the radius (Figure 1.1). A fall on 
the outstretched hand is the most common mechanism of injury. Other types of injury may 
cause different angulations and dislocations of the distal radius17. The majority of the distal 
radius fractures in the elderly are closed fractures where the overlying skin is intact. There 
are several treatment choices for dealing with a distal radius fracture. These depend on 
factors such as the mechanism of the injury, 
soft tissue condition, fracture type, intra-
articular component of the fracture, age of 
the patient and quality of the bone. If there 
is no or minimal dislocation, the fracture is 
normally stabilised by a plaster cast18. 
External fixation is often the treatment 
choice if the fracture is unstable, and 
dynamic fixation appears to be a better 
choice than static fixation in some types of 
distal radius fractures19.  
Figure 1.1 Fracture of the distal radius. From: American Academy of Orthopedic Surgeons, 
2007.  
1.1.2 Epidemiology of distal radius fracture 
The total incidence of distal radius fractures in Norway is estimated to be 10.9 per 1000 
women and 2.5 per 1000 men20. In a study from Bergen on adults over 20 years, the overall 
incidence of distal radius fractures was 3.8 per 1000, and 79% of the injured were women21. 
Most of the distal radius fractures in Bergen occur outdoors after a fall on slippery surfaces21. 
In older studies the incidence of distal radius fractures decreased or levelled off after the age 
of 6021, 22. However, in recent studies the incidence increases after the age of 45 years in 
women and continues to progress into older age20, 23. In younger age, the fracture is more 
common in boys than in girls, as confirmed by a study from Bergen on child fractures24. 
However, with increasing age, women predominate3.  
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1.1.3 Consequenses of distal radius fracture 
The long-term impact on quality of life after radius fracture is limited25. Most patients with a 
distal radius fracture have reduced function of the arm and pain during the first weeks after 
the fracture. Generally, distal radius fracture patients seem to attain arm and hand function 
about six months after the fracture, though many patients have residual symptoms associated 
with it26, 27.  
1.2 Osteoporosis 
The clinical consequence of osteoporosis is the increased risk of fragility fractures28, 29. 
Osteoporosis is asymptomatic and may remain disregarded until a fracture occurs. It is a 
question of definition whether osteoporosis should be regarded as a condition or a disease.  
1.2.1 Definition of osteoporosis
A descriptive definition of osteoporosis was formulated at a consensus development  
conference in Copenhagen in 1990: “Osteoporosis is a systemic disorder characterised by 
low bone mass and micro-architectural deterioration of the bone with a consequent increase 
in bone fragility and susceptibility to fracture”1. Bone fragility was also emphasised in 1994 
by the US National Institute of Health Consensus Development Conference on Osteoporosis 
Prevention: “Osteoporosis is a skeletal disorder characterised by compromised bone strength 
predisposing a person to an increased risk of fracture”29. Normal versus osteoporotic bone is 
shown in Figure 1.2. The World Health Organisation (WHO) operationalised the definition 
by establishing specific criteria for use in diagnostic practice30, 31, as listed in Table 1.1.  
Table 1.1 Diagnostic criteria for osteoporosis30, 31. 
Normal: Bone mineral density (BMD) or bone mineral content (BMC) that is no more than 
1 standard deviation (SD) below the mean of young adults 
Osteopenia (low BMD): BMD or BMC between 1 and 2.5 SD below the mean of young 
adults 
Osteoporosis: BMD or BMC 2.5 SD or more below the mean of young adults
Severe osteoporosis: BMD or BMC 2.5 SD or more below the mean of young adults in the 
presence of one or more fragility fractures 
The aim of defining osteoporosis according to these criteria was that these cut-off levels 
should reflect lifetime fracture risk among postmenopausal women from observational 
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studies. Consequently, the definitions could be used to estimate the prevalence of 
osteoporosis32. BMD values were standardised as T-score and Z-score, where T-score is 
defined as the SD units from the young adult mean, and Z-score as the SD from the mean of 
age- and sex-matched controls31. However, this classification depends on the young adult 
mean and the SD in the selected reference database. Further, reference data are supplied by 
the manufacturers of the various densitometries and vary according to the manufacturer. This 
leads to different T-score values even though the BMD data are the same. To account for 
this, official positions have been defined for reference data, measurement sites and the use of 
T- and Z-scores33. The latest recommendation suggests that the reference standard should be 
based on BMD measurement at the femoral neck with dual-energy X-ray absorptiometry 
(DXA). The recommended reference database is the US National Health and Nutrition 
Examination Survey (NHANES III) for femoral neck measurements in women aged 20-29 
years. An equal cut-off value for femoral neck BMD that is used to define osteoporosis in 
women can be used for men33. Osteoporosis may be diagnosed in women and men aged 50 
years and older if the T-score at femoral neck is −2.5 SD or less. However, multiple skeletal 
sites can be used; e.g. osteoporosis can be defined as a T-score  −2.5 SD in one of the 
following measurement sites: femoral neck, total hip or lumbar spine. The diagnostic 
sensitivity may be increased, but the prognostic ability is not improved34. The Z-score should 
be used rather than the T-score to evaluate BMD in people younger than 50 years33, 35.  
Several studies confirm that each 1 SD decline in BMD is associated with a 2-3 fold increase 
in the age-adjusted risk of hip fracture36-38. Although BMD is a strong predictor of fracture, it 
is only a surrogate measure. Variation in the level of BMD accounts for 60-70% of the 
variation in bone strength39. Bone strength also depends on the structural characteristics of 
the skeleton such as size, shape, geometry, three-dimensional architecture, micro-damage, 
remodelling action, and substance properites39-41. However, the micro-architecture and the 
other structural variables are difficult to measure. Methods to measure BMD are more readily 
available and large population samples can be measured in a relatively short time42. 
Fracture risk is also influenced by clinical factors, independently of BMD. The WHO 
developed the Fracture Risk Assessment Tool (FRAX®) algorithm to calculate the 10-year 
risk of hip fractures and major osteoporotic fractures (clinical spine, forearm, hip, or 
shoulder)43. FRAX® is based on clinical risk factors in combination with BMD. FRAX® has 
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been developed with the aim to better identify people at high risk of fracture so that 
treatments can be more effectively targeted44. The difficulty arises in identifying individuals 
at high fracture risk as fractures also occur in people with T-scores > −2.0 SD45-47. 
Acknowledging that BMD is obviously not the only factor determining bone strength and 
accepting the limitations of the WHO definition of osteoporosis, attention to BMD in this 
thesis is justified because BMD is very closely related to bone strength and fracture risk. 
Throughout this dissertation the term osteoporosis is used synonymously with the WHO 
definition, unless otherwise is stated. 
Figure 1.2 Normal and osteoporotic bone. From: Bone Health and Osteoporosis: A Report 
of the Surgeon General, 2004.  
1.2.2 Epidemiology of osteoporosis 
In Norway and the other Scandinavian countries the prevalence of osteoporosis and the 
incidence of low-energy fractures are among the highest worldwide20-22, 48-51. Approximately 
250,000 Norwegian women and 50,000 men aged 50 years and older have osteoporosis4. 
Every year Norwegians suffer from about 9,000 hip fractures, 15,000 forearm fractures and 
8,000 vertebral fractures4. In the year 2000 about 9 million new osteoporotic fractures 
occurred worldwide, of which 1.6 million were hip fractures, 1.7 million forearm fractures, 
and 1.4 million vertebral fractures3.  
1.2.3 Consequences of osteoporosis 
Osteoporotic fractures cause pain, suffering and reduced quality of life for the patients and 
the societal economic consequences are high3, 25. Hip and vertebral fractures are related to 
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increased risk of mortality52-56. In a recently published long-term follow-up study from 
Australia all fragility fractures in older age was associated with increased risk of death57. 
Among women over 44 years, osteoporotic fractures cause more hospital days than any other 
disease58. In another study from Australia, roughly every second woman and one in four men 
aged 60 years will experience a fracture during their remaining lifetime59.  
1.3 Assessment of bone mineral density - Dual-energy  
X-ray absorptiometry 
DXA is the most commonly used bone densitometry technique and is at present considered 
the “gold standard” for the non-invasive diagnosis of osteoporosis42, 60. Femoral neck is the 
recommended DXA site for estimating hip fracture risk33. Due to the two-dimensional scan 
used in DXA, only areal density, not true volumetric density is provided61. The BMD derived 
from DXA is the mass of bone mineral content (BMC) per unit area; not per unit volume. As 
BMD is not directly proportional to bone area, differences in bone thickness is not taken into 
account62.   
1.4 Bone metabolism 
Bone consists of an organic extra-cellular matrix containing mineral deposits where the 
major portion is collagen which accounts for 90% of skeletal weight in the adult. The 
skeleton undergoes continuous remodelling during life. Multinucleated cells, osteoclasts, 
resorb the calcified matrix, whereas osteoblasts synthesise new bone matrix which undergoes 
subsequent calcification. The remodelling process maintains bone strength and calcium 
homeostasis. About 10% of the skeleton is renewed each year. During about two weeks the 
bone resorption phase takes place. The osteoid formation phase takes about three months 
whereas the subsequent mineralisation phase takes up to one year63. Under regular 
conditions, bone resorption and formation are coupled processes. During the growth spurt 
bone turnover increases: formation exceeds resorption resulting in a net bone gain. At older 
age (postmenopausal), resorption exceeds formation, resulting in net bone loss. Bone 
turnover is higher in trabecular bone than in cortical bone. Trabecular bone is common in the 
distal forearm, hip and spine. The resorbing cells are modulated by cytokines and hormones, 
e.g. parathyroid hormone (PTH), 1.25-dihydroxyvitamin D (1.25(OH)2D), and calcitonin. 
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The formation of osteoclasts is regulated by inactive osteoblast cells which cover the bone 
surface. In osteoporosis the bone turnover is increased64. 
1.4.1 Calcium 
Calcium plays an important role in the growth of the skeleton and in cell development. 
Calcium is also important in preventing osteoporosis and fractures65. In the circulating blood, 
calcium is bound to proteins (albumin). The degree of protein binding depends on the pH 
level of the blood. The degree of binding is high in alkalosis and low in acidosis; a high pH 
level gives a low calcium level in the blood. Optimal calcium intake to ensure bone 
homeostasis seems to be 500-800 mg daily29. Elderly people with decreased BMD or 
osteoporosis may benefit from a higher intake66, 67. However, some data on vascular events 
suggest that a high supplemental calcium intake might have an adverse effect on vascular 
health68, 69.  
1.4.2 Parathyroid hormone 
PTH is a polypeptide hormone formed in the parathyroid glands. Synthesis and release of the 
hormone are regulated by the calcium concentration in the plasma. Low plasma calcium
concentration leads to increased PTH release. PTH is essential in the calcium homeostasis by 
acting directly on bone (stimulating mineral resorption) and kidney (stimulating calcium 
reabsorption). PTH also stimulates 1--hydroxylase action and thus increases the production 
of 1.25(OH)2D, which increases the intestinal calcium absorption70.  
1.4.3 Vitamin D  
The term vitamin D comprises the two fat-soluble components vitamin D3 (cholecalciferol) 
and vitamin D2 (ergocalciferol). Vitamin D3 is synthesised from 7-dehydrocholesterol in the 
skin during exposition to ultraviolet radiation, and this synthesising process is the most 
important vitamin D source in humans71. Vitamin D3 is also the major type of nutritional 
vitamin D72. Vitamin D2 comes mainly from vegetable sources, and vitamin D3 comes from 
animal sources like fatty fish and cod liver oil73 in addition to vitamin D enriched food like 
margarine and semi-skimmed milk72. In humans, vitamin D is hydroxylated in the liver to 
25-hydroxyvitamin D (25(OH)D)74. The circulating level of 25(OH)D is the most reliable 
marker for vitamin D status72. Severe and moderate vitamin D deficiency are defined as s-
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25(OH)D lower than 12.5 nmol/L and 12.5-25 nmol/L, respectively71. The most favourable 
level of vitamin D in respect to bone health has not been established but different thresholds 
have been proposed; s-25(OH)D > 30, > 50 and > 75 nmol/L71, 75, 76. However, results on the 
relationship between 25(OH)D, BMD, bone turnover, lower extremity function and falls, 
indicate that 50 nmol/L is an appropriate threshold to classify vitamin D inadequacy77. 
However, s-25(OH)D above 75 nmol/L is thought to be beneficial for the prevention of e.g. 
fractures, low BMD, high risk of falling, extremity weakness, poor dental health, cancer and 
hypertension78, 79. Nevertheless, the evidence for an association of 25(OH)D levels with 
fractures is not consistent73. 
One of the main functions of vitamin D is to contribute to maintaining stable serum calcium 
level. If serum calcium decreases, PTH is secreted from the parathyroidea. This stimulates 
the renal hydroxylation of 25(OH)D into 1.25(OH)2D which in turn increases the intestinal 
calcium absorption, the renal calcium reabsorption and the bone remodelling73. Thus, 
vitamin D and PTH together regulate calcium metabolism and influence bone health in 
balance with the hormone calcitonin that prevents hypercalcemia by stimulation deposition 
of calcium in the skeleton65. 
Epidemiology of vitamin D deficiency 
Worldwide, it is estimated that 1 billion people have vitamin D deficiency or insufficiency80. 
In Norway, a high prevalence of vitamin D deficiency among immigrants has been found. 
For example, in the study by Meyer et al81, mean 25(OH)D was 75 nmol/L in Norwegian 
women and 25 nmol/L in Pakistanis living in Norway. The high prevalence of vitamin D 
deficiency in immigrant groups is also mentioned in other studies82-85. In fracture patients 
from Germany and Northern Ireland it has been demonstrated that a large proportion of those 
with a distal radius fracture have vitamin D inadequacy86, 87. 
Consequences of vitamin D deficiency 
Severe deficiency of vitamin D is related to impaired mineralisation of recently produced 
bone and leads to rickets in children and osteomalacia in adults72, 88, 89. Low vitamin D levels 
are known to be associated with impaired general health and there is evidence of a link with
several common diseases90 as well as increased mortality91, 92. In less severe vitamin D 
deficiency, the decreased gastrointestinal absorption and renal reabsorption of calcium 
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stimulates the production of PTH, leading to secondary hyperparathyroidism and thereby to 
calcium release from the skeleton. Thus, people suffering from vitamin D deficiency are 
susceptible to osteoporosis and fractures71, 93. Vitamin D deficiency has also been associated 
with muscle weakness, leading to an increased risk of falling94. Vitamin D has a direct effect 
on muscle strength modulated by specific vitamin D receptors present in human muscle 
tissue95.
1.5 Risk factors for osteoporotic fractures 
Lifetime fracture risk is associated with a number of factors96. These are factors related to the 
trauma and/or factors related to bone strength97.  
1.5.1 Falls 
Most low-energy fractures occur in connection with a fall, and a previous fall is a strong 
predictor for new falls98-100. The prevalence of falls is higher in women than in men21, 101. A 
number of factors determine whether a fall results in a fracture or not. These mechanisms can 
be classified as internal and external factors. Internal factors are bone strength, the person’s 
height and weight, orientation of the fall, width of the movable tissue covering skeletal 
structures, nutritional status, inactivity (lack of exercise), medical condition, medications, 
and alterations related to aging (reduced visual acuity and cognitive impairment). External 
factors include the energy involved when falling, slippery surfaces such as ice or snow, 
resistance of the surface, light settings and grips99, 102.     
1.5.2 Bone mineral density  
BMD increases during adolescence and peaks at the age of 25-30 years, plateaus to the age of 
40, and declines after that28. Thus, attaining a high peak bone mass may protect against 
osteoporosis in later life. The prevalence of low BMD and osteoporosis increases radically 
with age; in women aged 50-59 years the worldwide prevalence is about 4%, while the 
prevalence is 40% in women aged 80 years and older103. Many studies show that next to age 
and sex, BMD is the strongest predictor of osteoporotic fractures36, 38, 104, 105, and that BMD 
of the proximal femur site is the best predictor of hip fracture37, 106. The association between 
BMD and fracture risk is continuous, with more than a doubling of fracture risk for each SD 
decline in BMD106.  
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1.5.3 Age, gender and ethnicity 
The risk of osteoporotic fractures increases with age23, 107 and is generally higher in women 
than men23, 101. About three of four hip fractures occur in women101. Generally, bone 
diameter and cortical thickness are greater in men than women. The risk/occurrence of distal 
radius fractures increases after the age of 45 in women20, 23, while few hip fractures occur 
before the age of 50101. Data from Sweden showed that lifetime risk for distal radius fracture 
at age 45 was 22% in women and 5% in men23.  
The incidence of hip fractures is higher in women of Caucasian origin than in women of 
Asian or African origin97. This has been demonstrated by comparing fracture incidence 
between countries, but also between different ethnic populations within the US108. 
1.5.4 Genetics 
Heritability data show that genetic factors may explain up to 80% of the difference in 
BMD109. A family history of hip and/or distal radius fracture is a risk factor for distal radius 
fracture110. However, a meta-analysis showed that a parental history of fracture gave an 
increased risk of fracture independently of BMD111. Certain genes have been identified to be 
associated with variations in BMD112, 113 and the risk of fractures109, 114.  
1.5.5 Previous fracture 
A history of a prior fracture at any location is a significant risk factor for subsequent 
fractures100, 115. One of the strongest risk factors for distal radius fractures is a previous low-
energy fracture116-118. Women with a prior distal radius fracture have a threefold risk of a 
new distal radius fracture115, and a distal radius fracture is a risk factor for a subsequent hip 
fracture both in women and men119. Any previous fracture is associated with a twofold 
relative risk of any subsequent fracture115, 120.  
1.5.6 Body weight and body height 
Low body mass index (BMI) or low body weight is strongly associated with low BMD121, 122
and increased fracture risk in both genders123-125. High BMI seems to protect against distal 
radius fracture117, 126. Weight loss is also related to a reduction in BMD and an increased risk 
of hip fracture in women and men127-130, whereas weight gain is found to decrease the risk of 
hip fracture131. Body height is positively associated with the risk of hip fractures125, 131. 
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1.5.7 Physical inactivity 
It has been documented that weight-bearing activities increase BMD132, and that physical 
activity protects against hip fracture133, 134. A recent review of prospective cohort studies 
concluded that moderate to vigorous physical activity was associated with a reduction of hip 
fractures of about 38% in women and 45% in men135. However, results from studies 
investigating physical activity and fracture risk are inconsistent117, 136. The duration and 
intensity of the training protocol may affect the results. Weight-bearing activities such as 
walking, running or strength training are beneficial in strengthening bones132, 137. Muscle 
strength is improved by strength training, which may reduce the tendency to fall, thus 
reducing the risk of fractures138. Both inactive and very active people have a higher tendency 
to fall than people with moderate activity135.  
1.5.8 Nutrition 
Insufficiencies of specific nutrients have been shown to affect bone139. Calcium, vitamin D, 
vitamin B12 and folate are frequently under-consumed by older people, and a relationship 
between poor diet and mortality is well recognised139. In a study from Oslo, participants with 
a vitamin D intake of less than 2,5 µg per day had an increased risk of hip fractures140. 
Randomised controlled trials show that high doses of vitamin D (700-1,000 IU per day, i.e. 
17.5-25 µg) reduce both the risk of falling141 and the risk of hip and other non-vertebral 
fractures142. In addition, other nutrients have been proposed as being important, including 
vitamin A143, vitamin K144, protein145 and fat146, including omega-3 fatty acids. However, 
vitamin A seems to have a negative effect on bone health. For example, in some studies a 
high dietary vitamin A intake was associated with a higher fracture risk in the general 
population, and with increased risk of hip fractures147, 148, and low BMD in women148. In a 
Norwegian study, women who reported having taken cod liver oil during childhood had 
lower forearm BMD than those who reported no such use143. In Norway, the vitamin A 
content of cod liver oil was recently reduced by 75%. However, in other studies no 
association between vitamin A, low BMD or fracture risk was found149, 150. 
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1.5.9 Smoking  
In both women and men current cigarette smoking is found to be associated with fractures in 
general151, hip fracture151, 152, and spine fracture, but not with distal radius fracture152. 
Furthermore, smokers have lower BMD and greater bone loss than non-smokers153, 154. The 
effect of smoking on fracture risk seems to be dose-dependent with an increasing risk with 
the years of smoking152, 155. Cigarette smokers have significantly lower body weight than 
non-smokers; however, lower BMI is unlikely to explain the increased risk of osteoporotic 
fractures in smokers151.     
1.5.10 Alcohol consumption 
In some studies alcoholism is found to be a risk factor for any osteoporotic fracture, hip 
fracture156, 157, and low BMD158. Increased fracture risk in alcoholics may result from the 
effect of ethanol or non-ethanol ingredients of alcoholic beverages on bone remodelling159, 
nutritional deficiencies or co-morbidity which increases the risk of falling156, 160. The effect 
of alcohol on bone seems to be dose-dependent, and moderate alcohol consumption (2 units 
or less daily) is not related to osteoporotic fracture or low BMD156. Some data suggest a 
positive effect on bone health of a moderate alcohol intake156, 161, 162.  
1.5.11 Co-morbidities and medication 
Many diseases, conditions, and medications are associated with increased risk of 
osteoporosis and fractures. Some types of medicine might increase fracture risk by increasing 
bone loss or having side effects which increase the tendency to fall. Fracture risk may be 
increased by diseases such as type I diabetes mellitus, primary hyperparathyroidism, hyper- 
and hypothyroidism, rheumatoid arthritis, stroke, hypertension, inflammatory bowel disease, 
celiac disease, gastrectomy, asthma, chronic obstructive pulmonary disease, cystic fibrosis, 
renal disease, anorexia nervosa, pernicious anaemia, Parkinson’s, dementia, and psychiatric 
disorders107, 131, 163-174. Reasons for an association might be e.g. inflammation, malabsorption, 
malnutrition, or a higher fall rate. 
1.6 Treatment guidelines for osteoporosis 
Guidelines from NMA suggest medical treatment for osteoporosis after a low-energy fracture 
when the T-score is less than −2.0 SD in subjects aged 50 years and older11. Scotland and 
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Sweden have similar guidelines175, 176, whereas other guidelines recommend treatment after 
low-energy fracture and a T-score  −2.5 SD177, 178. On the other hand, the UK National 
Institute of Health and Clinical Excellence (NICE) guideline recommends treatment for all 
women aged 75 years and older who have experienced a low-energy fracture regardless of 
the results of BMD measurements179. The various guidelines are based on risk reduction of 
pharmacological treatment and cost-effectiveness studies180-182 and on the fact that risk 
reduction is strongest in patients with low BMD and a previous fracture183-186.  
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2. Aims of the study 
A distal radius fracture results from a low-energy trauma exerted on a skeleton with varying 
degree of reduced bone strength and such a fracture may be the first sign of osteoporosis in 
women and men over 50 years old. Different guidelines exist as to which fracture patients 
should be treated for osteoporosis. However, previous studies of the prevalence of 
osteoporosis in distal radius fracture patients are relatively few and the number of 
participants is low187-192, and only some of the studies on this topic have included a control 
group188, 192, 193. Neither the proportion of  fracture patients in need of osteoporotic treatment 
according to Norwegian guidelines nor the risk of future hip fracture in a radius fracture 
cohort are known at present. Furthermore, investigations of vitamin D status in distal radius 
fracture patients and matched controls have as far as we know not previously been published. 
In Norway, none of these questions have hitherto been addressed.  
Thus, the overall aims were to investigate firstly the prevalence of osteoporosis in distal 
radius patients, secondly the association between distal radius fractures and osteoporosis, and 
thirdly the association between distal radius fractures and vitamin D inadequacy. 
The specific aims were to:  
1) Examine whether distal radius fracture patients have lower BMD than expected with 
regard to age and gender, and to estimate the risk of hip fracture and any osteoporotic 
fracture in this group of patients. 
2) Compare the prevalence of osteopenia and osteoporosis between individuals with low-
energy distal radius fracture and sex- and age-matched controls, and examine whether the 
observed differences in BMD between patients and controls could be explained by clinical 
risk factors.  
3) Determine vitamin D status (s-25(OH)D) in female and male low-energy distal radius 
fracture patients compared with matched controls, and investigate whether observed 
differences in vitamin D between patients and controls could explain the differences in 
BMD. 
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3. Participants and methods 
In 2003 an automatic referral to bone densitometry was etablished for all patients aged 50 
years and older who suffered a low-energy distal radius fracture in the three Norwegian 
towns Bergen, Kristiansand, and Skien. This practice was based on the Fracture Liaison 
Model set up in Glasgow191, 194.  
3.1 Study design and population  
The distal radius fracture patients were successively recruited from the referral centers for 
orthopedic trauma at the Bergen Accident and Emergency Department (AED) and 
Haukeland University Hospital (HUH) in Bergen (Papers I, II and III), Sørlandet Hospital in 
Kristiansand (Paper I) and Telemark Hospital in Skien (Paper I). The patients in Bergen were 
recruited from October 2003 to October 2007, in Kristiansand from December 2003 to 
December 2007 and in Skien from March 2003 to November 2007. The patients and controls 
were invited to the osteoporosis clinics for measurement of BMD, clinical risk score based 
on a questionnaire, and blood samples. 
A total of 2,349 women and 357 men were treated for a low-energy distal radius fracture in 
the catchment areas during the recruitment period and were invited to participate (Paper I). 
Of these, 67% of the women (n=1,576) and 61% of the men (n=218) came for examination. 
figure 3.1 gives an overview of the study population.  
In Papers II and III the subgroup of distal radius fracture patients from Bergen AED and 
HUH were included and a matched control group recruited in the period from April 2008 to 
June 2009 were included. During the inclusion period 1,252 female and 185 male patients 
were treated for low-energy distal radius fractures at Bergen AED and HUH. The study 
sample in Paper II comprised 664 female and 85 male patients aged 50-90 years. The 
corresponding numbers for Paper III were 575 and 72, respectively (Figure 3.1). The reasons 
why some patients did not participate and why some were excluded are described in Table 
3.1. 
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Figure 3.1 Flow-chart of the distal radius fracture patients and controls.  
W: women, M: men.*No hip BMD scans: W=51, M=6, **Participants >90 yrs: W=25, M=3, non-Caucasian: W=6. 
§Participants >90 yrs: W=5, >6 months from fracture to BMD scan: W=7, M=1. §§No blood samples: W=89, M=13. 
•Previous low-energy distal radius fracture: W=54, M=1. No BMD scans: W=4. ••No blood samples: W=20, M=2.  
Participants 
Papers I-III 
2003-07 
>50 yrs 
Paper I 
Participants from 
Bergen, Kr.sand 
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Papers II-III 
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Patients  
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 M=218 
Did not meet 
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M=139 
Did not meet
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M=99 
Did not meet
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M=117 
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 M=86 
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BMD analyses*   
W=51, M=6       
Excluded FRAX
analyses**       
W=31, M=3       
Excluded Papers 
II-III§
W=12, M=1 
Excluded Paper 
III§§
W=90, M=14 
Excluded Papers 
II-III•
W=58, M=1 
Excluded Paper 
III••
W=20, M=2 
Included 
patients Paper 
II  
W=664 
M=85 
Included 
controls Paper 
II  
W=554 
M=54 
Included 
patients Paper 
III 
W=575 
M=72 
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controls Paper 
III 
W=534 
M=52 
Included hip 
BMD analyses   
 W=1,525 
M=212         
Included FRAX 
analyses        
W=1,545 
 M=215        
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Table 3.1 An overview of why some patients did not participate and why some were  
excluded in Papers II and III.   
Female patients Male patients 
Did not meet for unknown reasons 230 61 
Dementia, confusion or illness 194 27 
Previous evaluation for osteoporosis 117 4 
Tourists 35 7 
Evaluated more than 6 months after the 
current fracture 
7 1 
Older than 90 years 5 0 
No blood samples* 89 13 
Total 677 113 
*Relevant for Paper III. 
Control subjects were recruited from the general population in the same area as the fracture 
patients. They were randomly selected by Statistics Norway from the Norwegian Population 
Registry, matched by town of residence, age (+ 2 years), sex, and month of examination. 
Two control subjects per case were selected and invited by mail to participate; 1352 women 
and 172 men. The study sample in Paper II comprised 554 female and 54 male controls aged 
50-90 years. The corresponding numbers for Paper III were 534 and 52 (Figure 3.1). 
3.2 Demographic and clinical data 
3.2.1 Questionnaires  
The same self-administered questionnaire was used for all distal radius fracture patients 
(Appendix 3) and a similar questionnaire was used for the controls (Appendix 4). The 
questionnaire was handed out and filled in on the day of examination and participants were 
offered help by an experienced nurse if needed.  
3.2.2 Bone mineral density measurements 
All scanning procedures and analyses were conducted by trained medical staff following the 
same protocol. BMD was measured by DXA at all study sites. Prodigy (GE Lunar, Madison, 
Wisconsin) was used in Bergen and Kristiansand and EXPERT-XL (GE Lunar, Madison, 
Wisconsin) was used in Skien. The same DXA equipment was used during the whole study 
period. The results were based on the measurements at total hip, femoral neck, and L2-L4. 
The measurement regions of the hip are shown in figure 3.2. 
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Figure 3.2 Proximal femur DXA scan showing the measurement regions; femoral neck 
(oblong box), Ward’s area (box), trochanter (upper triangle), shaft (lower triangle), and total 
hip.  
The DXA machines were calibrated daily and were stable during the whole examination 
period. The in vivo short-term precision for total hip, femoral neck and L2-L4 measurements 
was 0.77%, 1.47%, and 1.36% in Bergen, 0.89%, 1.56%, and 1.19% in Kristiansand, and 
0.80%, 1.58%, and 1.50% in Skien, respectively. The in vitro long-term precision expressed 
as the coefficient of variation (CV %) was 0.86% in Bergen, 0.62% in Kristiansand, and 
0.92% in Skien, respectively. A European spine phantom (ESP) was used to compare the 
three DXA machines, and no significant differences were found. 
The average time from current fracture to BMD assessment and data collection at the 
osteoporosis clinics is shown in Table 3.2. In Papers II and III, eight patients examined more 
than 6 months after the fracture were excluded.  
Table 3.2 Time in days from the current distal radius fracture to data collection.  
Mean number of days and range. 
 Paper I Paper II Paper III 
Female patients 49 (0-634) 66 (6-169) 63 (7-169) 
Male patients 41 (0-183) 63 (18-156) 58 (18-152) 
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BMD was categorised according to the definitions of osteoporosis (T-score  –2.5 SD), 
osteopenia (T-score < –1.0, > –2.5 SD), and normal BMD (T-score  –1.0 SD)31. In addition, 
the NMA treatment guidelines (T-score  –2.0 SD)11 and a Z-score cut-off < –1.0 SD were 
used in Paper I.  
3.2.3 Reference population 
BMD T-score and Z-score were calculated from a combined European/US reference 
population as incorporated in the accompanying software195, 196. Scores were gender-specific 
and the reference population for the calculation of T-score was young adults aged 20-40. A 
Z-score < –1.0 SD was defined as reduced BMD (>1 SD below the age- and weight-matched 
mean of Lunar).  
3.2.4 Fracture risk assessed by FRAX®   
As no FRAX® model is accessible in Norway, we used the Swedish FRAX® model, version 
3.0, to estimate the 10-year risk of hip fractures and any major osteoporotic fractures (clinical  
spine, forearm, hip, or shoulder) (Paper I)43. The algorithm is based on a series of meta-
analyses of data from 12 studies from around the world, including North America, Europe, 
Asia and Australia. It has been validated in independent cohorts104. The risk factors included 
in the model are: age, sex, weight, height, femoral neck BMD (g/cm2), previous fracture, 
parental history of hip fracture, current smoking, use of oral glucocorticoids for more than 
three months, rheumatoid arthritis, other secondary causes of osteoporosis (type I diabetes, 
osteogenesis imperfecta, hyperthyroidism, hypogonadism, early menopause (< 45 years), 
chronic malnutrition, malabsorption and chronic liver disease), and alcohol intake of three or 
more units per day. The model can be used with or without femoral neck BMD43. The 
FRAX® calculations in our study were performed by the WHO collaborating centre for 
metabolic bone diseases.  
3.2.5 Biochemical analyses 
All serum samples were analysed at the Hormone Laboratory, HUH and the Laboratory for 
Clinical Biochemistry, HUH (Paper III). A radioimmunoassay from Immunodiagnostic 
System, Boldon, UK was used to measure 25(OH)D. The interassay CV percentages were 
8.2%, 8.1%, and 7.3% for concentrations of 19.6, 56.7, and 136 nmol/L, respectively. 
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Colorimetric assays with a Roche/Hitachi Modular analyser (Roche Diagnostics GmbH, 
Germany) were used to measure serum calcium and albumin. The interassay variations were 
2.0% for calcium at a concentration of 2.44 mmol/L and 2.0% for albumin at a concentration 
of 44.0 g/L. Serum calcium was corrected for serum albumin by the equation: serum calcium 
(mmol/L) + (40 – serum albumin) x 0.02.   
3.3 Statistical analyses 
Paper I  
The proportion of patients with indication for treatment (T-score  −2.0 SD) and 
osteoporosis (T-score  −2.5 SD) were estimated among women and men and in ten-year age 
spans. BMD levels in our group of fracture patients were compared with the reference 
population in the Lunar database, and the proportion of individuals with a Z-score  −1.0 SD 
was evaluated195. Assuming a normal distribution, the expected proportion of Z-score  −1.0 
SD is 16% by default. The 95% confidence interval (CI) range for proportions of patients 
having a Z-score of  −1.0 SD was calculated using the equation for binomial distribution197.  
Paper II  
Independent sample t-tests were used for comparison of continuous variables and chi-square 
tests for comparison of categorical variables between fracture patients and controls and 
between age categories. Age was stratified at 50-64 and 65-90 years. Women were further 
divided into ten-year age spans. Odds ratios (ORs) for distal radius fracture were estimated in 
unadjusted conditional logistic regression analyses separately for the different demographic 
and clinical risk factors. Variables from the unadjusted analyses with a p-value  0.20 were 
included in the adjusted analyses. 
Paper III 
Independent sample t-tests for comparison of continuous variables and chi-square tests for 
comparison of categorical variables between fracture patients and controls were used. ORs 
for distal radius fracture were estimated in unadjusted and adjusted conditional logistic 
regression analyses for 25(OH)D. In the adjusted analyses the estimates of s-25(OH)D were 
adjusted for femoral neck BMD (g/cm2), BMI (kg/m2), and smoking. A generalised additive 
logistic regression model (GAM) was used for the dose-response relation between 25(OH)D 
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nmol/L, and OR for distal radius fractures. The model was adjusted for femoral neck BMD 
(g/cm2), BMI (kg/m2), age, and smoking. 
P-values below 0.05 were considered statistically significant. All analyses were performed 
using SPSS software for Windows, version 15.0 (SPSS Inc., Chicago, Illinois).  
3.4 Approvals 
The study was approved by the Norwegian National Data Inspectorate and the Regional 
Committee for Medical Research Ethics, Western Norway. All participants gave written 
consent to participate. 
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4. Main results 
The main results from the three papers (I, II and III) are presented below, together with some 
additional results for the study presented in Paper II.  
4.1 Paper I  
The prevalence of distal radius fracture patients with indication for treatment according to 
NMA guidelines (T-score  −2.0 SD) at femoral neck was 51% among women (n=1,525), 
and 38% among men (n=212). The prevalence of osteoporosis (T-score  −2.5 SD) was 31% 
in women and 20% in men. About 64% of the women and 49% of the men had a T-score 
−2.0 SD at one or more measurement sites. Corresponding figures for osteoporosis were 
45% and 33%, respectively. Within ten-year age groups the prevalence of a T-score  −2.0 
SD was approximately equal in women and men. The proportion of women and men aged 75 
years and older with osteoporosis was 54% and 33%, respectively. Compared to the 
reference population, a reduced age and weight adjusted BMD (expressed as Z-score) in the 
fracture group was observed. In fracture risk assessment analyses by FRAX® the ten-year risk 
of hip fracture calculated with BMD was 9% in women and 6% in men. The corresponding 
percentages for women and men with osteoporosis were 18% and 16%. 18% of the women 
with a FRAX® score >15% for the risk of hip fracture calculated with BMD did not have 
osteoporosis. The corresponding figure in men was 15%. When the same figures were 
calculated without BMD, 46% of the women and 44% of the men did not have osteoporosis.  
4.2 Paper II 
The prevalence of osteoporosis measured at femoral neck was 34% in female patients 
(n=654) and 10% in female controls (n=546). Corresponding values in male patients (n=85) 
and controls (n=54) were 17% and 13%, respectively. When all three measurement sites 
were considered, the prevalence increased in both patients and controls (Table 4.1). In the 
age group 50-59 years, 18% of the female patients and 5% of the female controls had 
osteoporosis. The corresponding numbers for the age group 60-69 years were 25% and 7%. 
Among men aged 50-64, 14% of patients and 11% of controls had osteoporosis. The 
corresponding figures for the age group 65-90 years were 20% and 15%. In conditional 
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logistic regression analyses adjusted for BMI, hip fracture in a parent, previous fracture, and 
early menopause, osteopenia (OR=2.7, 95% CI: 1.9-3.9, p<0.001), and osteoporosis (OR 6.8, 
95% CI: 4.1-11.2, p<0.001) were significantly associated with distal radius fractures in 
women. Osteoporosis (OR=8.1, 95% CI: 1.4-47.4, p=0.021) was significantly associated 
with distal radius fractures in men after adjustment for BMI, current smoking, and hip 
fracture in one of the parents.  
Table 4.1 Prevalence of normal BMD, osteopenia and osteoporosis in one of the 
measurement sites total hip, femoral neck or spine (L2-L4). Data are given as numbers (%). 
Female Male 
Patients Controls p-value* Patients Controls p-value* 
Normal BMD 
Osteopenia 
Osteoporosis 
63 (10) 
273 (41) 
328 (49) 
150 (27) 
276 (50) 
128 (23) 
< 0.001 11 (13) 
45 (53) 
29 (34) 
15 (28) 
27 (50) 
12 (22) 
0.063 
*Overall p-value for the categorised variable. Normal BMD: T-score  –1.0 SD. Osteopenia: T-score < –1.0, > 
–2.5 SD. Osteoporosis: T-score  –2.5 SD. 
4.3 Paper III 
Mean s-25(OH)D was 66.5 nmol/L in female patients (n=575) compared to 78.7 nmol/L in 
female controls (n=534) (p<0.001). The corresponding figures in male patients (n=72) and 
controls (n=52) were 64.5 and 77.0 nmol/L (p=0.017), respectively. In conditional logistic 
regression analyses adjusted for BMI (kg/m2), smoking, and BMD (g/cm2), s-25(OH)D < 50 
nmol/L (OR=2.3, 95% CI: 1.5-3.6, p<0.001), and 50-75 nmol/L (OR=1.7, 95% CI: 1.2-2.5, 
p=0.005) were associated with distal radius fractures in women, and s-25(OH)D < 50 nmol/L 
(OR=6.27, 95% CI: 1.2-33.7, p=0.032) was associated with distal radius fractures in men. A 
dose-response relationship between vitamin D and distal radius fracture was found for 
vitamin D levels up to approximately 100 nmol/L in both genders.  
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5. Discussion  
The strengths of this study are that we were able to include a large number of patients with 
distal radius fractures consecutively in the clinical work, and a large number of matched 
controls.  
5.1 Methodological considerations 
This study is an epidemiological research project. A major goal for epidemiological research 
is to identify subgroups in populations that are at high risk of disease.  
5.1.1 Study design  
Paper I is a cross-sectional study (descriptive study); this study design is useful for 
estimating prevalence. A cross-sectional study can also be suggestive of potential risk factors 
when an association is found. We have used this design to estimate the prevalence of 
osteoporosis among patients with a distal radius fracture. Compared to the reference 
population, a reduced BMD was observed. Low BMD is a risk factor for fracture. Generally, 
a cross-sectional study design has limitations in establishing a temporal relationship between 
exposure and outcome. However, it seems unlikely for a fracture to occur first and 
osteoporosis second because it takes several years to develop osteoporosis.  
Papers II and III are case-control studies; these are classified as analytic studies because they 
make use of a comparison group. In these two papers, the outcome variable is radius fracture. 
Case-control studies are frequently used in epidemiological research and allow researchers to 
evaluate both diseases with long latency periods and exposure variables associated with a 
given outcome. The outcome is always identified previously to the exposure, thus case-
control studies are retrospective in character198.  
  
5.1.2  Selection bias 
Participation rate 
In spite of the large number of patients and controls, selection bias may have influenced our 
results because of a large proportion of non-attendees among both cases and controls. The 
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oldest age groups had a particularly low participation rate. Demographic comparisons 
between attendees and non-attendees are not fully available, but we have information about 
why some patients from Bergen did not participate. Many female patients had previously 
been examined for osteoporosis and therefore chose not to participate. If many of them 
already had been diagnosed with osteoporosis, the prevalence of osteoporosis in our study 
may have been underestimated, leading in turn to a possible underestimation of the 
difference in BMD between patients and controls. Drop-out reasons among controls are 
unknown, but some control subjects may also have declined to participate because they had 
already been treated for osteoporosis. If this were the case, the prevalence of osteoporosis 
may have been underestimated in this group as well. Thus, selection bias might have affected 
both groups. The degree of possible underestimation of osteoporosis and its influence on the 
results are unknown. 
5.1.3 Information bias 
BMD measurements  
The operator technique may influence BMD outcome (Paper I) and exposure (Papers II and 
III). In this study the procedures recommended by the manufacturer of the bone densitometry 
machines were strictly adhered to and the scans revealed no major errors (Papers I, II and 
III). The same stable DXA device was used throughout the inclusion period at each study 
centre. We tested the reliability of the bone densitometry scans at the study sites with the 
European Spine Phantom (ESP), and found no significant differences between the results at 
the different study sites.    
Timing: In the present study, DXA measurements and assessment of clinical risk factors 
were conducted on average within two months of the current distal radius fracture. The 
maximum delay from fracture to examination was 634 days (Table 3.2). In Papers II and III 
we decided to exclude patients with DXA measurements and blood samples taken more 
than six months after the current distal radius fracture. This was done to avoid results being 
affected by e.g. the use of anti-osteoporotic treatment between fracture and examination. 
Thus, theoretically the BMD results in Paper I could have been biased by delayed 
examination. However, only one man and seven women had their BMD measured after 6 
months. No differences were observed in results after excluding these participants. BMD 
was measured by DXA at the total hip, femoral neck and spine (L2-L4), and not at the 
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wrist. These measurement sites were chosen because data have shown that BMD 
measurements at these sites are better predictors of e.g. hip fracture risk38 than 
measurements from peripheral sites33, 35. However, measurement at the wrist is a better 
predictor for fracture risk at the distal radius35. 
Reference population: BMD was measured as T-score and Z-score derived from a combined 
European/US reference population in the accompanying software195, 196. As we did not have 
any young healthy reference group from our own districts, this reference population was used 
as a control group in our study (Paper I). Ideally our data should have been compared with a 
large reference group from the districts of Bergen, Kristiansand, and Skien. The Lunar 
reference population used has been found to correspond well with the general Norwegian 
population at all age groups195, 199. However, in a study from Tromsø, the authors found that 
the prevalence of osteoporosis at the femoral neck was 20% in women and 14% in men aged 
70 years and older, using the Lunar reference material for T-score calculations. The 
prevalence increased significantly to 35% in women and 19% in men when T-scores were 
calculated on the basis of the young adult mean BMD (age group 30-39 years) in the study 
population200. Thus, a population-specific T-score estimation may have led to a higher 
proportion of osteoporosis among both patients and controls in our study. According to the
International Society for Clinical Densitometry (ISCD), international reference data are 
recommended for diagnostic purposes as we have done. The comparison made in Paper I by 
evaluating Z-scores is, however, highly dependent on the suitability of the reference 
population. The generally lower BMD among Norwegians will overestimate the importance 
of BMD for distal radius fractures. In Paper II we have included a specific control population 
to account for this possible bias.  
Assessment of distal radius fractures 
All distal radius fractures among the patients were radiographically confirmed. There is some 
difficulty in the classification of fractures as low-energy or high-energy. The fall mechanism 
can vary, and a fall can in fact resemble a high-energy trauma even if it happens from 
standing height. 
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Questionnaires 
The questionnaires were derived from similar questionnaires, such as the Hordaland Health 
Study, and based on known risk factors for osteoporosis from previous research. Differences 
in interpretation of the questionnaire could have resulted in an information bias.  
Previous fractures: Among the patients and controls, previous distal radius fractures after the 
age of 50 years were self-reported. The controls who reported a previous distal radius 
fracture were excluded from the study. The retrospective study design may introduce recall 
bias, and the controls may have had difficulty in knowing what kind of fractures we were 
asking for. Thus, earlier distal radius fracture patients might have been misclassified as 
controls. Furthermore, self-reported fractures have low validity201. Other types of fractures 
were also self-reported, which could have underestimated or overestimated the proportion of 
previous fractures.  
FRAX®: The optimal estimate of alcohol consumption as a risk factor according to FRAX® is 
three or more units per day. This is a yes/no question in the FRAX® algorithm. In our study, 
participants only reported whether or not they considered themselves to be alcohol abusers. If 
moderate alcohol consumption is a risk factor for fractures, our results may have been biased 
and the 10-year risk of fractures underestimated. As an example, in a woman aged 60 years, 
with BMI 23 kg/m2, a low-energy fracture and normal BMD, the hip fracture risk increases 
by 0.7% when alcohol of three or more units per day is reported. Similarly a woman with 
osteoporosis who reports three or more units of alcohol per day increases her FRAX® risk by 
3%.  
Patients and controls 
The Norwegian population suffers more fragility fractures than other populations4, 48, 202, 203, 
and within Norway, regional differences in hip BMD have been documented, e.g. lower hip 
BMD among women and men aged 60 years and above from Bergen compared to Tromsø204. 
We therefore found it important to include a matched control group from the same 
geographical area as the distal radius fracture patients. All participants in our study were 
examined at the same clinic, by the same staff, in the same month of the year as their 
matched fracture patients, with the same DXA machine, and the with same assay for 
25(OH)D, which was stable throughout the inclusion period. However, a weakness of our 
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study is that our control subjects were included from six months to four years after the 
patients were assessed. It would have been a more reliable design if we had included the 
controls at the same time as the patients. 
Biochemical analyses 
The association between vitamin D and fracture is based on the assumption that the vitamin 
D level we have measured reflects the normal vitamin D level of the individual (Paper III). 
Our vitamin D results might have been influenced by time spent abroad in sunnier countries, 
or the use of a solarium previously to the blood tests. Unfortunately, we did not ask for this 
information. High levels of sun exposure in a low proportion of participants may have led to 
a small overestimate of vitamin D in both groups. Blood samples were handled similarly 
regardless of group. Equivalent procedures were performed for all participants and the blood 
samples were prepared for analysis according to strict procedures. So although the controls 
were included after the patients, we believe the validity of the vitamin D blood samples was 
satisfactory as the CVs were 8.2%, 8.1%, and 7.3% for concentrations of 19.6, 56.7, and 136 
nmol/L, respectively.   
5.1.4 Confounding  
Paper II 
The controls were matched at inclusion and as we used conditional logistic regression 
analyses, which are designed for matched case-control studies, adjustment for age was not 
needed as this was a matching variable. In this kind of analysis, a missing variable leads to 
exclusion of the matched pair. For example, if the variable previous fracture is lacking in a 
fracture patient, the matched control (the pair) is excluded from the analysis. ORs for distal 
radius fracture were estimated in unadjusted and adjusted regression analyses independently 
for the different demographic and clinical risk factors. We have included potential 
confounding variables in the analyses previously reported in the literature. We can however 
not rule out that some data may have been insufficiently measured or controlled for, and 
there may be residual confounding. Misclassification of information regarding hip fracture in 
a parent, previous fracture, and early menopause may have occurred, but the extent and 
impact of such bias are probably minor. Further, we decided to use the categorical BMI (< 
22 kg/m2) variable in the regression analyses. The continuous variable, BMI kg/m2, was 
tested but the results did not change significantly compared to the findings when using the 
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dichotomized variable. Age (± 2 years) was one of the variables we used in matching the 
controls, and advanced age is a strong risk factor for osteoporotic fractures23, 107. We did not 
adjust for bone-active drugs. The data were analysed both with and without participants 
using these drugs, with no significant differences in the results. This was also done in Paper 
III. As with other variables retrospectively collected, the participants might have had 
problems remembering or knowing what kind of drugs they were using. 
Paper III        
The control subjects were matched on month of examination due to the factor of Norwegian 
climatic sun exposure. Unfortunately, as described earlier, other sources of sun exposure 
were not investigated. Thus, vitamin D could have been unnaturally high in some of the 
patients and controls, which could have been a confounding factor in this paper. Low BMI 
may be an indicator of insufficient nutritional status and vitamin D inadequacy. Moreover, 
low BMI is associated with increased fracture risk in both genders123-125, 205. High BMI 
appears to be protective against distal radius fracture117, 126, 206. However, nutritional status 
was not investigated in this study. In any case, the confounding factors we investigated are 
known risk factors for osteoporotic fractures121-125, 151-154, 205, 207. Cigarette smoking is 
associated with increased risk of osteoporotic fractures151, 152, but not with distal radius 
fractures152. Cigarette smokers are generally leaner than non-smokers, which can affect 
BMD151, 152, and low BMD is a risk factor for fractures36, 104, 105. However, lower BMI among 
smokers has not been found to explain the increased risk of osteoporotic fractures151. We 
decided to make an adjustment for smoking. The analyses were also performed without 
including smoking and the results did not change significantly. 
5.1.5  External validity 
Even though many of the patients with distal radius fracture did not participate, one of the 
strengths in this study was the high number of included patients. In Paper I these fracture 
patients were included from different parts of Norway (west, south and east), consequently 
we believe that our findings can be generalised to other parts of the country. However, the 
prevalence of low BMD and osteoporosis will probably differ somewhat depending on the 
BMD devices and other factors such as e.g. BMI. Differences in BMD have previously been 
reported between Northern and Western Norway204. Our main conclusion that low-energy 
distal radius fracture patients aged 50 years and older should be referred to bone 
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densitometry and evaluated by clinical risk factors, can most probably be generalised. 
Despite some degree of selection bias, we believe our results in Papers II and III are 
generalisable, and that distal radius fracture is strongly associated with osteoporosis (Paper 
II). Other researchers have found similar results in individuals with other types of low-energy 
fractures36, 38, 104-106. 
Within Norway the prevalence of vitamin D deficiency is found to differ most between 
ethnic Norwegians and immigrant groups81. Only Caucasians were included in Paper II and 
III. The association between vitamin D inadequacy and distal radius fracture can probably be 
generalised to other Norwegian regions but not to immigrants living in Norway, nor to distal 
radius fracture populations in other parts of Europe. The prevalence of vitamin D inadequacy 
in our material is lower than in studies from other geographical regions86, 87. Apart from the 
different measurement methods used in previous studies, vitamin D status has also been 
calculated to be higher among Scandinavians than in people from Central Europe208. 
5.2 Discussion of specific results and comparison with 
other studies 
5.2.1 Prevalence of osteoporosis and treatment guidelines (Paper I) 
A high prevalence of low BMD (T-score  −2.0 SD) and osteoporosis (T-score  −2.5 SD) 
among fracture patients indicates the importance of following up these patients with bone 
densitometry, as these patients benefit from anti-osteoporotic treatment183-186, 209. In a 
substantial proportion of men, including the youngest, anti-osteoporotic treatment was 
indicated according to Norwegian guidelines. On the other hand, a relatively high proportion 
of the patients did not have an indication for treatment. BMD is only one of several 
important factors that contribute to fracture risk, and a high percentage of patients with a 
high FRAX® score did not have osteoporosis. 
Our results on the prevalence of osteoporosis among distal radius fracture patients 
correspond well with other investigations. In a study from Sweden, 53% of the patients had 
T-scores < −2.0 SD and 37% had osteoporosis at either the hip or spine measurement site190. 
Another Swedish study showed a prevalence of osteoporosis at 34%187 at the same 
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measurement sites. Similarly, in a study from Scotland, 41% of the patients had 
osteoporosis191, and in women from Korea, 32% had osteoporosis measured at femoral 
neck210. Both higher and lower prevalence of osteoporosis among distal radius fracture 
patients are reported; Bahari and co-workers188 diagnosed osteoporosis at hip or spine in as 
many as 68% of Irish female distal radius fracture patients. In contrast, only 24% of the 
British patients in the study by Lashin & Davie189 were diagnosed with osteoporosis. In men, 
there are limited data and the results show more variation. In one British study193 the 
prevalence of osteoporosis at total hip, femoral neck or spine was higher (42%) than in our 
study (33%), while in two studies from Scotland191, 211 the prevalence was lower (23%). 
Generally, these studies have small numbers of participants compared to our study. Although 
DXA devices were used, variation in measurement results between individual devices may 
explain some of the differences. Previous studies have shown the prevalence of osteoporosis 
and fractures in Scandinavia to be among the highest in the world20, 49, 50. Nevertheless, the 
proportion of distal radius fracture patients with osteoporosis does not seem to be higher in 
Norway compared to other populations.  
Following publication, our results initiated a debate about recommended clinical practice. In 
agreement with Blank and co-workers (Appendix 1), our results indicate that follow-up of 
distal radius patients is important. However, a relatively high proportion of the patients with 
distal radius fractures in our study did not have indications for treatment for osteoporosis. 
The main statement by Blank and co-workers is that a low-energy fracture is the key 
manifestation of osteoporosis regardless of BMD, thus a low-energy fracture is synonymous 
with osteoporosis. In our response letter (Appendix 2) to Blank and co-workers we argued 
that evidence-based medicine should be the leading principle in treatment decisions. There is 
no evidence for the effect of drug treatment in reducing the fracture risk in patients with 
normal or slightly subnormal T-scores. However, we know that BMD is only one of several 
important factors contributing to skeletal fragility, and our FRAX® results indicate that those 
patients with normal BMD have as high a risk for subsequent hip fractures as patients with 
low BMD. Based on this, we agree that clinical risk factors have a high impact in addition to 
BMD. So far, DXA is the “gold standard” for the non-invasive diagnosis of osteoporosis42, 
60, and BMD is the single best predictor of osteoporotic fractures36, 104. Hopefully, in the 
future alternative techniques for the imaging and quantifying of bone strength, together with 
advanced methods of imaging bone quality, will be available for routine clinical use. We 
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concluded that referral to bone densitometry should be done consistently in these patients, to 
offer treatment to patients with osteoporosis or BMD values close to osteoporosis, but also to 
identify patients with normal BMD whom we believe to have no need for osteoporosis 
medication.  
5.2.2 Distal radius fracture and osteoporosis (Paper II) 
The prevalence of osteoporosis was significantly higher in distal radius fracture patients than 
in matched controls. Osteoporosis was found to be an isolated risk factor for distal radius 
fracture in both women and men. The results from this paper support our conclusion in Paper 
I. Although distal radius fractures are not as strongly associated with increased mortality as 
hip fractures53, those patients with low BMD have an increased fracture risk, and an 
increased severity of the distal radius fracture has been observed212. As the follow-up of such 
patients is generally low8-10, 213, an alteration of current practice is necessary.  
There are few studies on distal radius fracture patients and matched controls. However, our 
results are in accordance with a Spanish study where 19% of the female distal radius fracture 
patients were diagnosed with osteoporosis measured at total hip compared to 6% of the 
control subjects192. Contrary to our findings, osteopenia and osteoporosis were only 
significant in the youngest age-group ( 65 years). In an Irish study188, as many as 68% of 
the female distal radius fracture patients had osteoporosis at either the total hip or spine 
measurement site compared to 28% of the controls. In male distal radius fracture patients 
only one study with a control group was found193; in UK patients the prevalence of 
osteoporosis at femoral neck (37%) was higher than in our male patients (17%). Their 
controls had a lower prevalence of osteoporosis (9%) than our controls (13%). In regression 
analysis low BMD was associated with distal radius fracture after adjustment for age and 
BMI193. DXA measurement was used in all studies, but still variation in measurement results 
may occur. The numbers of participants vary and different regression methods were used, as 
well as adjustment for different risk factors.  
5.2.3 Distal radius fracture and vitamin D inadequacy (Paper III) 
We found an inverse relationship between vitamin D levels and distal radius fracture. The 
results remained significant after adjustment for BMD, BMI, and smoking. However, only a 
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few distal radius fracture patients had severe or moderate vitamin D deficiency (25(OH)D < 
25 nmol/L). Previous data suggest that 25(OH)D levels above 75 nmol/L are beneficial for 
several health outcomes including fracture, fall prevention, BMD, and extremity strength78. 
Thus, an increased focus on distal radius fracture patients to identify risk factors will lead to 
preventive treatment for both osteoporosis5, 214 and vitamin D inadequacy93.  
Previous studies investigating the association between vitamin D inadequacy and distal 
radius fractures are few. In a Dutch study87 the proportion of female and male patients with 
low BMD (T-score  −2.0 SD) and 25(OH)D levels below 50 nmol/L was much higher 
(69%) than in our patients with osteoporosis (34%). However, the prevalence of 
osteoporosis was similar to our results (58% versus 51%, respectively). In male distal radius 
fracture patients from Northern Ireland86 the vitamin D inadequacy (< 50 nmol/L) was 49% 
compared to 33% in our study. In the latter study the prevalence of osteoporosis was lower 
(11%) than in our study (18%). This may be explained by the lower mean age of the 
Northern Irish participants compared to our study (54 years versus 65 years). As already 
mentioned, relatively high levels of vitamin D are also found in other groups of patients 
from Scandinavia with osteoporosis215. As the sun exposure in Scandinavia is relatively low, 
one theory is that the high intake of cod liver oil208, 216 which increases vitamin D levels, 
might also increase the risk of fractures. The previously high vitamin A content in cod liver 
oil143 has been postulated to have a negative effect on BMD, thus increasing fracture risk143, 
147, 148. This high level, which was above recommended values, has now been reduced. 
However, in a large case-control study from Denmark, high doses of vitamin A was not 
associated with increased fracture risk150.  
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6. Conclusions 
In the present study we found a relatively high prevalence of low BMD and osteoporosis in 
distal radius fracture patients. Furthermore, a substantial proportion of patients with a high 
FRAX® score, and a substantial proportion of patients aged 75 years and older did not have 
osteoporosis. Hence, referral to bone densitometry and examination of potential risk factors 
seems to be a good strategy in order to identify patients with distal radius fractures in need of 
anti-osteoporotic treatment. So far, there is no evidence that anti-osteoporotic treatment 
prevents new fractures unless osteoporosis is present.  
Osteoporosis was associated with distal radius fracture in both women and men after 
adjustment for confounding factors. The prevalence of osteoporosis was significantly higher 
in the female patients compared to matched control subjects. In addition, vitamin D 
inadequacy was associated with distal radius fractures in both genders. The variations in 
vitamin D levels between patients and controls were independent of differences in BMD, 
BMI, or smoking history. Hence, bone densitometry, vitamin D samples, and examination of 
risk factors for osteoporosis should be performed in all patients aged 50 years and older with 
a low-energy distal radius fracture. These examinations could be integrated in the normal 
clinical routine to facilitate adequate anti-osteoporotic treatment thus preventing more 
serious fractures (e.g. hip fracture) in later life. 
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7. Future research 
Follow-up studies of the distal radius fracture patients and the matched controls from Bergen 
will be performed. The hip fracture risk among distal radius fracture patients and controls 
will be assessed and the implications of BMD levels will be investigated. Adherence to 
treatment guidelines will be investigated by coupling our data with the Norwegian 
Prescription Register. 
An extensive randomised controlled trial is needed to investigate whether radius fracture 
patients with normal or slightly reduced BMD will benefit from anti-osteoporotic treatment. 
Treatment with bisphosphonates is potentially harmful and risk benefit analyses are needed 
before new indications are established. Future research should also aim to assess other 
parameters associated to bone strength to clarify the mechanism of fragility in patients with a 
low-energy fracture and normal BMD, e.g. peripheral quantitative computed tomography
(pQCT)217. Studies should also seek further clarification on the effect mechanisms of vitamin 
D on bone and the possible negative consequences that extensive use of calcium supplements 
might have in the treatment of osteopenia and osteoporosis.   
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